EA200901365A1 - Стабилизированная фармацевтическая композиция, содержащая прегабалин - Google Patents

Стабилизированная фармацевтическая композиция, содержащая прегабалин

Info

Publication number
EA200901365A1
EA200901365A1 EA200901365A EA200901365A EA200901365A1 EA 200901365 A1 EA200901365 A1 EA 200901365A1 EA 200901365 A EA200901365 A EA 200901365A EA 200901365 A EA200901365 A EA 200901365A EA 200901365 A1 EA200901365 A1 EA 200901365A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pharmaceutical composition
composition containing
stabilized pharmaceutical
pregabalin
containing pregabalin
Prior art date
Application number
EA200901365A
Other languages
English (en)
Inventor
Юлия Шульце-Наруп
Александер Леманн
Франк Мускюлус
Original Assignee
Рациофарм Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Рациофарм Гмбх filed Critical Рациофарм Гмбх
Publication of EA200901365A1 publication Critical patent/EA200901365A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Твердая фармацевтическая композиция, содержащая: (a) прегабалин в качестве действующего вещества и (b) одно или несколько фармацевтических вспомогательных веществ, при этом композиция, по существу, не содержит сахариды и не содержит дополнительные аминокислоты кроме прегабалина.
EA200901365A 2007-04-23 2008-04-23 Стабилизированная фармацевтическая композиция, содержащая прегабалин EA200901365A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007019071A DE102007019071A1 (de) 2007-04-23 2007-04-23 Stabilisierte pharmazeutische Zusammensetzung enthaltend Pregabalin
PCT/EP2008/003285 WO2008128775A2 (en) 2007-04-23 2008-04-23 Stabilised pharmaceutical composition containing pregabaline

Publications (1)

Publication Number Publication Date
EA200901365A1 true EA200901365A1 (ru) 2010-04-30

Family

ID=39777371

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200901365A EA200901365A1 (ru) 2007-04-23 2008-04-23 Стабилизированная фармацевтическая композиция, содержащая прегабалин

Country Status (13)

Country Link
US (1) US20100151012A1 (ru)
EP (1) EP2148656A2 (ru)
JP (1) JP2010524991A (ru)
KR (1) KR20100015764A (ru)
CN (1) CN101663025A (ru)
AU (1) AU2008240960A1 (ru)
BR (1) BRPI0809661A2 (ru)
CA (1) CA2681587A1 (ru)
DE (1) DE102007019071A1 (ru)
EA (1) EA200901365A1 (ru)
IL (1) IL201035A0 (ru)
WO (1) WO2008128775A2 (ru)
ZA (1) ZA200907450B (ru)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010115612A2 (en) * 2009-04-10 2010-10-14 Synthon B.V. Pregabalin compositions
TR200909613A1 (tr) 2009-12-22 2011-07-21 Sanovel İlaç San. Ve Ti̇c. A.Ş. Pregabalinin farmasötik bileşimleri.
TR201005241A1 (tr) * 2010-05-25 2012-01-23 Sanovel �La� San. Ve T�C. A.�. Kontrollü salım sağlayan pregabalin solüsyon formülasyonu.
EP2389933A1 (en) 2010-05-25 2011-11-30 Sanovel Ilac Sanayi ve Ticaret A.S. Controlled-Release Pregabalin Compositions
EP2389934A1 (en) 2010-05-25 2011-11-30 Sanovel Ilac Sanayi ve Ticaret A.S. Controlled-Release Tablet Formulations of Pregabalin
CN102793685B (zh) * 2012-08-14 2017-09-22 浙江华海药业股份有限公司 含有普瑞巴林的口服胶囊及其制备方法
US9937153B2 (en) 2013-08-30 2018-04-10 Merck Sharp & Dohme Ltd. Oral pharmaceutical formulation of omarigliptin
CN103948564B (zh) * 2014-04-22 2016-05-11 青岛市中心医院 一种普瑞巴林胶囊及其制备方法
EP3362054B1 (en) * 2015-10-14 2021-04-14 Laboratorios Lesvi, S.L. Pregabalin compositions
CN105520918B (zh) * 2015-12-31 2018-12-11 常州市阳光药业有限公司 普瑞巴林胶囊
JP6919119B2 (ja) * 2017-01-23 2021-08-18 日新製薬株式会社 ３位が置換されたγ−アミノ酪酸誘導体を含有する圧縮固形医薬組成物。
JP2019142834A (ja) * 2017-07-31 2019-08-29 大原薬品工業株式会社 プレガバリン並びに好適な賦形剤を含有する固形製剤
EP3720424B1 (en) * 2017-12-08 2022-09-21 F. Hoffmann-La Roche AG Pharmaceutical formulation
JP6504638B1 (ja) * 2018-05-31 2019-04-24 武田テバファーマ株式会社 錠剤及びその製造方法
CN112245404A (zh) * 2020-11-02 2021-01-22 成都晶富医药科技有限公司 一种普瑞巴林胶囊及其制备方法
MX2022015331A (es) 2020-12-04 2023-02-01 Laboratorios Silanes S A De C V Composicion farmaceutica solida recubierta y estable de un analgesico opioide y un antiepileptico para el dolor.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9019198A (en) * 1997-08-19 1999-03-08 Warner-Lambert Company Methods for treating physiological conditions associated with the use, or sequelae of use, of cocaine or other psychomotor stimulants
AU769038B2 (en) * 1998-05-15 2004-01-15 Warner-Lambert Company Llc Gamma-aminobutyric acid derivatives containing, solid compositions and process for preparing the same
ID27724A (id) 1998-05-15 2001-04-26 Warner Lambert Co Penstabil sediaan parmasi dari turunan-turunan asam gamma-aminobutira dan proses pembuatannya
CA2373953A1 (en) * 1999-07-02 2001-01-11 Warner-Lambert Company A synergistic combination: gabapentin and pregabalin
FR2795962B1 (fr) * 1999-07-08 2003-05-09 Prographarm Laboratoires Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif
AP2002002501A0 (en) * 1999-10-07 2002-06-30 Warner Lambert Co Synergistic combinations of an NK1 receptor antagonist and a gaba structural analog.
US7022678B2 (en) * 2001-03-30 2006-04-04 Warner-Lambert Company Pregabalin lactose conjugates
ATE334656T1 (de) * 2001-05-25 2006-08-15 Warner Lambert Co Flüssige pharmazeutische zusammensetzung
US20060159743A1 (en) * 2001-10-25 2006-07-20 Depomed, Inc. Methods of treating non-nociceptive pain states with gastric retentive gabapentin
ATE345120T1 (de) * 2003-03-21 2006-12-15 Dynogen Pharmaceuticals Inc Verfahren zur behandlung von erkrankungen der unteren harnwege mit antimuskarinika und mit modulatoren der alpha-2-delta untereinheit des kalziumkanals
EP1543831A1 (en) * 2003-12-18 2005-06-22 Pfizer GmbH Arzneimittelwerk Gödecke Pregabalin composition
WO2006121557A1 (en) 2005-05-10 2006-11-16 Teva Pharmaceutical Industries Ltd. Pregabalin free of lactam and a process for preparation thereof

Also Published As

Publication number Publication date
CA2681587A1 (en) 2008-10-30
ZA200907450B (en) 2010-06-30
DE102007019071A1 (de) 2008-10-30
WO2008128775A3 (en) 2009-04-23
KR20100015764A (ko) 2010-02-12
IL201035A0 (en) 2010-05-17
US20100151012A1 (en) 2010-06-17
EP2148656A2 (en) 2010-02-03
AU2008240960A1 (en) 2008-10-30
BRPI0809661A2 (pt) 2014-10-14
JP2010524991A (ja) 2010-07-22
CN101663025A (zh) 2010-03-03
WO2008128775A2 (en) 2008-10-30

Similar Documents

Publication Publication Date Title
EA200901365A1 (ru) Стабилизированная фармацевтическая композиция, содержащая прегабалин
ECSP088800A (es) Formulaciones de inhibidores de DPP IV
EA200870599A1 (ru) Стабильные препараты лаквинимода
EA200802170A1 (ru) Лиофилизированная композиция терапевтического пептидного антитела
EA201071218A1 (ru) Улучшенные композиции для активных фармацевтических компонентов с плохой проницаемостью
DE602006014990D1 (de) Intranasale verabreichung von schnell wirkendem insulin
ATE534383T1 (de) Zusammensetzungen aus n-ä2,4-bis(1,1- dimethylethyl)-5-hydroxyphenylü-1,4-dihydro-4- oxochinolin-3-carboxamid
RU2008139905A (ru) Фармацевтическая композиция для наружного применения
EA200970532A1 (ru) Фумаратная соль (альфа s, бета r)-6-бром-альфа-[2-(диметиламино)этил]-2-метокси-альфа-1-нафталенил-бета-фенил-3-хинолинэтанола
ECSP088962A (es) Nuevos herbicidas
RS53056B (en) PHARMACEUTICAL PREPARATION CONTAINING (1S) -1,5-ANHYDRO-1- [5- (4-ETHOXYBENZYL) -2-METHOXY-4-METHYLPHENYL] -1-THI-D-GLUCITOL AND METFORMIN AND ITS USE IN THE TREATMENT OF DIABETES
EA200700976A1 (ru) Соединения в виде молекул-конъюгатов, обладающих повышенной активностью в отношении включения клеткой
BRPI0620229A8 (pt) formulação
EA200801926A1 (ru) Таблетки парацетамола с быстрым высвобождением
CL2007003540A1 (es) Compuestos derivados de macrociclos, inhibidores de la proteasa serina de hepatitis c; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de la hepatitis c.
EA200800698A1 (ru) Способ стабилизации фармацевтических форм для введения, включающих микроорганизмы
ATE510537T1 (de) Pharmazeutische zusammensetzungen von entacapon, levodopa und carbidopa mit verbesserter bioverfügbarkeit
EA201000391A1 (ru) Соединение, представляющее собой ингибитор гликогенфосфорилазы, и его фармацевтическая композиция
CY1108231T1 (el) Σταθερη στερεα δοσολογικη μορφη περιλαμβανουσα δεσμοπρεσσινη
EA200701228A1 (ru) Стабильные композиции фенофибрата с эфирами жирных кислот
WO2009120389A8 (en) Oral and injectable formulations of tetracycline compounds
EA201000392A1 (ru) Соединение, представляющее собой ингибитор гликогенфосфорилазы, и его фармацевтическая композиция
EA201071309A1 (ru) Твердая фармацевтическая композиция
JO3684B1 (ar) صور متبلرة من الملح ثنائي الصوديوم لحمض n-(5-كلورو ساليسلويل)-8-امينو كابريليك
ATE472316T1 (de) Haarbehandlungszusammensetzungen